CMT2A2A
MCID: CHR660
MIFTS: 34

Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a (CMT2A2A)

Categories: Genetic diseases, Metabolic diseases, Neuronal diseases, Rare diseases, Skin diseases

Aliases & Classifications for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type...

MalaCards integrated aliases for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a:

Name: Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a 58
Cmt2a2 58 60 76
Charcot-Marie-Tooth Disease, Axonal, Type 2a2a 58 30
Charcot-Marie-Tooth Disease, Axonal, Type 2a2 58 74
Hereditary Motor and Sensory Neuropathy Iia2 58 76
Charcot-Marie-Tooth Disease, Type 2a2a 30 6
Hmsn Iia2 58 76
Cmt2a2a 58 76
Hmsn2a2 58 76
Autosomal Dominant Charcot-Marie-Tooth Disease Type 2a2 60
Charcot-Marie-Tooth Disease, Axonal, Type 2a2; Cmt2a2 58
Hereditary Motor and Sensory Neuropathy Iia2; Hmsn2a2 58
Charcot-Marie-Tooth Disease, Neuronal, Type 2a2 58
Charcot-Marie-Tooth Disease Neuronal Type 2a2 76
Charcot-Marie-Tooth Disease Axonal Type 2a2 76
Charcot-Marie-Tooth Neuropathy, Type 2a2 58
Charcot-Marie-Tooth Neuropathy Type 2a2 76
Charcot-Marie-Tooth Disease 2a2a 76

Characteristics:

Orphanet epidemiological data:

60
autosomal dominant charcot-marie-tooth disease type 2a2
Inheritance: Autosomal dominant; Age of onset: Childhood;

OMIM:

58
Inheritance:
autosomal dominant

Miscellaneous:
variable severity
slowly progressive
variable age at onset (childhood to age 50)
earlier onset is associated with a more severe disorder
usually begins in feet and legs (peroneal distribution), but may progress to upper limbs
one family with a fatal subacute encephalopathy has been reported
up to 25% of patients are asymptomatic or mildly affected, suggesting incomplete penetrance


HPO:

33
charcot-marie-tooth disease, axonal, autosomal dominant, type 2a2a:
Onset and clinical course variable expressivity incomplete penetrance slow progression
Inheritance autosomal dominant inheritance autosomal recessive inheritance


Classifications:

Orphanet: 60  
Rare neurological diseases


Summaries for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type...

OMIM : 58 Charcot-Marie-Tooth disease constitutes a clinically and genetically heterogeneous group of hereditary motor and sensory neuropathies. On the basis of electrophysiologic criteria, CMT is divided into 2 major types: type 1, the demyelinating form, characterized by a slow motor median nerve conduction velocity (NCV) (less than 38 m/s), and type 2, the axonal form, with a normal or slightly reduced NCV. Distal hereditary motor neuropathy (dHMN), also known as spinal CMT, is a third type of CMT characterized by normal motor and sensory NCV and degeneration of spinal cord anterior horn cells. See CMT1B (118200) and CMT1A (118220) for descriptions of autosomal dominant slow nerve conduction types of Charcot-Marie-Tooth disease. See CMT4A (214400) and CMTX1 (302800) for autosomal recessive and X-linked forms of Charcot-Marie-Tooth disease, respectively. For a discussion of genetic heterogeneity of CMT type 2, see 118210. (609260)

MalaCards based summary : Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a, also known as cmt2a2, is related to charcot-marie-tooth disease type 2a2, and has symptoms including pain An important gene associated with Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a is MFN2 (Mitofusin 2). Affiliated tissues include spinal cord, skin and brain, and related phenotypes are sensory axonal neuropathy and foot dorsiflexor weakness

UniProtKB/Swiss-Prot : 76 Charcot-Marie-Tooth disease 2A2A: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.

Related Diseases for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type...

Diseases in the Charcot-Marie-Tooth Disease, Axonal, Type 2e family:

Charcot-Marie-Tooth Disease, Axonal, Type 2a1 Charcot-Marie-Tooth Disease, Axonal, Type 2b
Charcot-Marie-Tooth Disease, Axonal, Type 2d Charcot-Marie-Tooth Disease, Axonal, Type 2b1
Charcot-Marie-Tooth Disease, Axonal, Type 2b2 Charcot-Marie-Tooth Disease, Axonal, Type 2f
Charcot-Marie-Tooth Disease, Axonal, Type 2i Charcot-Marie-Tooth Disease, Axonal, Type 2h
Charcot-Marie-Tooth Disease, Axonal, Type 2j Charcot-Marie-Tooth Disease, Axonal, Type 2k
Charcot-Marie-Tooth Disease, Axonal, Type 2l Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a
Charcot-Marie-Tooth Disease, Axonal, Type 2n Charcot-Marie-Tooth Disease, Axonal, Type 2o
Charcot-Marie-Tooth Disease, Axonal, Type 2p Charcot-Marie-Tooth Disease, Axonal, Type 2q
Charcot-Marie-Tooth Disease, Axonal, Type 2r Charcot-Marie-Tooth Disease, Axonal, Type 2u
Charcot-Marie-Tooth Disease, Axonal, Type 2v Charcot-Marie-Tooth Disease, Axonal, Type 2w
Charcot-Marie-Tooth Disease, Axonal, Type 2x Charcot-Marie-Tooth Disease, Axonal, Type 2z
Charcot-Marie-Tooth Disease, Axonal, Type 2cc Charcot-Marie-Tooth Disease, Axonal, Type 2t
Charcot-Marie-Tooth Disease, Axonal, Autosomal Recessive, Type 2a2b Charcot-Marie-Tooth Disease, Axonal, Type 2dd
Charcot-Marie-Tooth Disease, Axonal, Type 2ee Autosomal Recessive Axonal Charcot-Marie-Tooth Disease Due to Copper Metabolism Defect

Diseases related to Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 charcot-marie-tooth disease type 2a2 11.8

Symptoms & Phenotypes for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type...

Human phenotypes related to Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a:

60 33 (show top 50) (show all 64)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 sensory axonal neuropathy 60 33 hallmark (90%) Very frequent (99-80%) HP:0003390
2 foot dorsiflexor weakness 60 33 hallmark (90%) Very frequent (99-80%) HP:0009027
3 absent achilles reflex 60 33 hallmark (90%) Very frequent (99-80%) HP:0003438
4 emg: chronic denervation signs 60 33 hallmark (90%) Very frequent (99-80%) HP:0003444
5 pes cavus 60 33 frequent (33%) Frequent (79-30%) HP:0001761
6 poor fine motor coordination 60 33 frequent (33%) Frequent (79-30%) HP:0007010
7 impaired pain sensation 60 33 frequent (33%) Frequent (79-30%) HP:0007328
8 distal lower limb muscle weakness 60 33 frequent (33%) Frequent (79-30%) HP:0009053
9 frequent falls 60 33 frequent (33%) Frequent (79-30%) HP:0002359
10 difficulty climbing stairs 60 33 frequent (33%) Frequent (79-30%) HP:0003551
11 difficulty running 60 33 frequent (33%) Frequent (79-30%) HP:0009046
12 impaired vibratory sensation 60 33 frequent (33%) Frequent (79-30%) HP:0002495
13 hand muscle weakness 60 33 frequent (33%) Frequent (79-30%) HP:0030237
14 distal sensory impairment 60 33 frequent (33%) Frequent (79-30%) HP:0002936
15 hand tremor 60 33 frequent (33%) Frequent (79-30%) HP:0002378
16 impaired temperature sensation 60 33 frequent (33%) Frequent (79-30%) HP:0010829
17 paresis of extensor muscles of the big toe 60 33 frequent (33%) Frequent (79-30%) HP:0002601
18 increased laxity of ankles 60 33 frequent (33%) Frequent (79-30%) HP:0006460
19 foot pain 60 33 frequent (33%) Frequent (79-30%) HP:0025238
20 muscle spasm 33 frequent (33%) HP:0003394
21 dysphonia 60 33 occasional (7.5%) Occasional (29-5%) HP:0001618
22 optic atrophy 60 33 occasional (7.5%) Very rare (<4-1%) HP:0000648
23 flexion contracture 60 33 occasional (7.5%) Occasional (29-5%) HP:0001371
24 babinski sign 60 33 occasional (7.5%) Occasional (29-5%) HP:0003487
25 vocal cord paralysis 60 33 occasional (7.5%) Occasional (29-5%) HP:0001605
26 paresthesia 60 33 occasional (7.5%) Occasional (29-5%) HP:0003401
27 hoarse voice 60 33 occasional (7.5%) Occasional (29-5%) HP:0001609
28 postural tremor 60 33 occasional (7.5%) Occasional (29-5%) HP:0002174
29 steppage gait 60 33 occasional (7.5%) Occasional (29-5%) HP:0003376
30 quadriceps muscle weakness 60 33 occasional (7.5%) Occasional (29-5%) HP:0003731
31 abnormality of the spinal cord 60 33 occasional (7.5%) Occasional (29-5%) HP:0002143
32 distal lower limb amyotrophy 60 33 occasional (7.5%) Occasional (29-5%) HP:0008944
33 restless legs 60 33 occasional (7.5%) Occasional (29-5%) HP:0012452
34 absent patellar reflexes 60 33 occasional (7.5%) Occasional (29-5%) HP:0006844
35 upper limb pain 60 33 occasional (7.5%) Occasional (29-5%) HP:0012513
36 triceps weakness 60 33 occasional (7.5%) Occasional (29-5%) HP:0031108
37 inability to walk by childhood/adolescence 60 33 occasional (7.5%) Occasional (29-5%) HP:0006915
38 spasticity 33 occasional (7.5%) HP:0001257
39 tremor 33 occasional (7.5%) HP:0001337
40 hyperreflexia 33 occasional (7.5%) HP:0001347
41 hearing impairment 33 occasional (7.5%) HP:0000365
42 mental deterioration 33 occasional (7.5%) HP:0001268
43 hydrocephalus 60 33 very rare (1%) Very rare (<4-1%) HP:0000238
44 scoliosis 60 33 very rare (1%) Very rare (<4-1%) HP:0002650
45 sensorineural hearing impairment 60 33 very rare (1%) Very rare (<4-1%) HP:0000407
46 nyctalopia 60 33 very rare (1%) Very rare (<4-1%) HP:0000662
47 hypertonia 33 HP:0001276
48 abnormality of the foot 60 Very frequent (99-80%)
49 areflexia of lower limbs 60 Frequent (79-30%)
50 decreased motor nerve conduction velocity 33 HP:0003431

Symptoms via clinical synopsis from OMIM:

58
Skeletal Feet:
pes cavus
foot deformities
hammer toes

Neurologic Peripheral Nervous System:
areflexia
hyporeflexia
distal sensory impairment
distal limb muscle weakness due to peripheral neuropathy
distal limb muscle atrophy due to peripheral neuropathy
more
Head And Neck Ears:
hearing loss (uncommon)

Skeletal Spine:
scoliosis (in those with early onset)

Neurologic Central Nervous System:
pain
cognitive decline (1 family)
spasticity (1 family)
pyramidal features (rare)
tremor (rare)
more
Head And Neck Eyes:
optic atrophy (uncommon)

Skeletal:
contractures (in those with early onset)

Clinical features from OMIM:

609260

UMLS symptoms related to Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a:


pain

Drugs & Therapeutics for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type...

Search Clinical Trials , NIH Clinical Center for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a

Genetic Tests for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type...

Genetic tests related to Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a:

# Genetic test Affiliating Genes
1 Charcot-Marie-Tooth Disease, Type 2a2a 30 MFN2
2 Charcot-Marie-Tooth Disease, Axonal, Type 2a2a 30

Anatomical Context for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type...

MalaCards organs/tissues related to Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a:

42
Spinal Cord, Skin, Brain

Publications for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type...

Articles related to Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a:

(show all 16)
# Title Authors Year
1
Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations. ( 21715711 )
2011
2
Phenotypic spectrum of MFN2 mutations in the Spanish population. ( 19889647 )
2010
3
Severe CMT type 2 with fatal encephalopathy associated with a novel MFN2 splicing mutation. ( 20530328 )
2010
4
Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations. ( 18458227 )
2008
5
Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction. ( 18946002 )
2008
6
Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. ( 16437557 )
2006
7
Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. ( 16835246 )
2006
8
Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A. ( 15549395 )
2005
9
Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations. ( 16087932 )
2005
10
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. ( 15064763 )
2004
11
Absence of KIF1B mutation in a large Turkish CMT2A family suggests involvement of a second gene. ( 15136675 )
2004
12
CMT with pyramidal features. Charcot-Marie-Tooth. ( 12601114 )
2003
13
Clinical and genetic study of a large Charcot-Marie-Tooth type 2A family from southern Italy. ( 11148244 )
2001
14
Linkage mapping of the gene for Charcot-Marie-Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A. ( 9409358 )
1997
15
Confirmation of a second locus for CMT2 and evidence for additional genetic heterogeneity. ( 10732809 )
1997
16
Localization of a gene (CMT2A) for autosomal dominant Charcot-Marie-Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity. ( 8406488 )
1993

Variations for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type...

UniProtKB/Swiss-Prot genetic disease variations for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a:

76 (show all 11)
# Symbol AA change Variation ID SNP ID
1 MFN2 p.Val69Phe VAR_018607 rs28940296
2 MFN2 p.Leu76Pro VAR_018608 rs28940293
3 MFN2 p.Arg94Gln VAR_018609 rs28940291
4 MFN2 p.Pro251Ala VAR_018610 rs28940295
5 MFN2 p.Arg280His VAR_018611 rs28940294
6 MFN2 p.Trp740Ser VAR_018612 rs28940292
7 MFN2 p.Lys357Asn VAR_022464 rs119103261
8 MFN2 p.Arg364Trp VAR_029880 rs119103265
9 MFN2 p.Leu233Val VAR_067088
10 MFN2 p.Glu744Met VAR_067089
11 MFN2 p.Arg707Trp VAR_078443 rs119103267

ClinVar genetic disease variations for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a:

6 (show top 50) (show all 62)
# Gene Variation Type Significance SNP ID Assembly Location
1 MFN2 NM_014874.3(MFN2): c.281G> A (p.Arg94Gln) single nucleotide variant Pathogenic rs28940291 GRCh37 Chromosome 1, 12052717: 12052717
2 MFN2 NM_014874.3(MFN2): c.281G> A (p.Arg94Gln) single nucleotide variant Pathogenic rs28940291 GRCh38 Chromosome 1, 11992660: 11992660
3 MFN2 NM_014874.3(MFN2): c.2219G> C (p.Trp740Ser) single nucleotide variant Pathogenic rs28940292 GRCh37 Chromosome 1, 12071567: 12071567
4 MFN2 NM_014874.3(MFN2): c.2219G> C (p.Trp740Ser) single nucleotide variant Pathogenic rs28940292 GRCh38 Chromosome 1, 12011510: 12011510
5 MFN2 NM_014874.3(MFN2): c.227T> C (p.Leu76Pro) single nucleotide variant Pathogenic rs28940293 GRCh37 Chromosome 1, 12052663: 12052663
6 MFN2 NM_014874.3(MFN2): c.227T> C (p.Leu76Pro) single nucleotide variant Pathogenic rs28940293 GRCh38 Chromosome 1, 11992606: 11992606
7 MFN2 NM_014874.3(MFN2): c.839G> A (p.Arg280His) single nucleotide variant Pathogenic rs28940294 GRCh37 Chromosome 1, 12061480: 12061480
8 MFN2 NM_014874.3(MFN2): c.839G> A (p.Arg280His) single nucleotide variant Pathogenic rs28940294 GRCh38 Chromosome 1, 12001423: 12001423
9 MFN2 NM_014874.3(MFN2): c.751C> G (p.Pro251Ala) single nucleotide variant Pathogenic rs28940295 GRCh37 Chromosome 1, 12059087: 12059087
10 MFN2 NM_014874.3(MFN2): c.751C> G (p.Pro251Ala) single nucleotide variant Pathogenic rs28940295 GRCh38 Chromosome 1, 11999030: 11999030
11 MFN2 NM_014874.3(MFN2): c.205G> T (p.Val69Phe) single nucleotide variant Pathogenic rs28940296 GRCh37 Chromosome 1, 12052641: 12052641
12 MFN2 NM_014874.3(MFN2): c.205G> T (p.Val69Phe) single nucleotide variant Pathogenic rs28940296 GRCh38 Chromosome 1, 11992584: 11992584
13 MFN2 NM_014874.3(MFN2): c.1071G> C (p.Lys357Asn) single nucleotide variant Likely pathogenic rs119103261 GRCh37 Chromosome 1, 12062071: 12062071
14 MFN2 NM_014874.3(MFN2): c.1071G> C (p.Lys357Asn) single nucleotide variant Likely pathogenic rs119103261 GRCh38 Chromosome 1, 12002014: 12002014
15 MFN2 NM_014874.3(MFN2): c.493C> G (p.His165Asp) single nucleotide variant Pathogenic rs119103262 GRCh37 Chromosome 1, 12057372: 12057372
16 MFN2 NM_014874.3(MFN2): c.493C> G (p.His165Asp) single nucleotide variant Pathogenic rs119103262 GRCh38 Chromosome 1, 11997315: 11997315
17 MFN2 NM_014874.3(MFN2): c.280C> T (p.Arg94Trp) single nucleotide variant Pathogenic rs119103263 GRCh37 Chromosome 1, 12052716: 12052716
18 MFN2 NM_014874.3(MFN2): c.2119C> T (p.Arg707Trp) single nucleotide variant Pathogenic/Likely pathogenic rs119103267 GRCh38 Chromosome 1, 12009641: 12009641
19 MFN2 NM_014874.3(MFN2): c.280C> T (p.Arg94Trp) single nucleotide variant Pathogenic rs119103263 GRCh38 Chromosome 1, 11992659: 11992659
20 MFN2 NM_014874.3(MFN2): c.1090C> T (p.Arg364Trp) single nucleotide variant Pathogenic rs119103265 GRCh37 Chromosome 1, 12062090: 12062090
21 MFN2 NM_014874.3(MFN2): c.1090C> T (p.Arg364Trp) single nucleotide variant Pathogenic rs119103265 GRCh38 Chromosome 1, 12002033: 12002033
22 MFN2 NM_014874.3(MFN2): c.2119C> T (p.Arg707Trp) single nucleotide variant Pathogenic/Likely pathogenic rs119103267 GRCh37 Chromosome 1, 12069698: 12069698
23 MFN2 NM_014874.3(MFN2): c.310C> T (p.Arg104Trp) single nucleotide variant Pathogenic rs119103268 GRCh37 Chromosome 1, 12052746: 12052746
24 MFN2 NM_014874.3(MFN2): c.310C> T (p.Arg104Trp) single nucleotide variant Pathogenic rs119103268 GRCh38 Chromosome 1, 11992689: 11992689
25 MFN2 NM_014874.3(MFN2): c.1403G> A (p.Arg468His) single nucleotide variant Conflicting interpretations of pathogenicity rs138382758 GRCh37 Chromosome 1, 12064892: 12064892
26 MFN2 NM_014874.3(MFN2): c.1403G> A (p.Arg468His) single nucleotide variant Conflicting interpretations of pathogenicity rs138382758 GRCh38 Chromosome 1, 12004835: 12004835
27 MFN2 NM_014874.3(MFN2): c.1392+2T> C single nucleotide variant Pathogenic rs111723244 GRCh37 Chromosome 1, 12064672: 12064672
28 MFN2 NM_014874.3(MFN2): c.1392+2T> C single nucleotide variant Pathogenic rs111723244 GRCh38 Chromosome 1, 12004615: 12004615
29 MFN2 NM_001127660.1(MFN2): c.1085C> T (p.Thr362Met) single nucleotide variant Likely pathogenic rs387906991 GRCh37 Chromosome 1, 12062085: 12062085
30 MFN2 NM_001127660.1(MFN2): c.1085C> T (p.Thr362Met) single nucleotide variant Likely pathogenic rs387906991 GRCh38 Chromosome 1, 12002028: 12002028
31 MFN2 NM_001127660.1(MFN2): c.775C> T (p.Arg259Cys) single nucleotide variant Pathogenic/Likely pathogenic rs587777875 GRCh37 Chromosome 1, 12059111: 12059111
32 MFN2 NM_001127660.1(MFN2): c.775C> T (p.Arg259Cys) single nucleotide variant Pathogenic/Likely pathogenic rs587777875 GRCh38 Chromosome 1, 11999054: 11999054
33 MFN2 NM_001127660.1(MFN2): c.746C> T (p.Ser249Phe) single nucleotide variant Pathogenic rs794729198 GRCh38 Chromosome 1, 11999025: 11999025
34 MFN2 NM_001127660.1(MFN2): c.746C> T (p.Ser249Phe) single nucleotide variant Pathogenic rs794729198 GRCh37 Chromosome 1, 12059082: 12059082
35 MFN2 NM_014874.3(MFN2): c.436C> T (p.Leu146Phe) single nucleotide variant Likely pathogenic rs863224969 GRCh37 Chromosome 1, 12056337: 12056337
36 MFN2 NM_014874.3(MFN2): c.436C> T (p.Leu146Phe) single nucleotide variant Likely pathogenic rs863224969 GRCh38 Chromosome 1, 11996280: 11996280
37 MFN2 NM_014874.3(MFN2): c.494A> G (p.His165Arg) single nucleotide variant Pathogenic rs863224970 GRCh38 Chromosome 1, 11997316: 11997316
38 MFN2 NM_014874.3(MFN2): c.494A> G (p.His165Arg) single nucleotide variant Pathogenic rs863224970 GRCh37 Chromosome 1, 12057373: 12057373
39 MFN2 NM_014874.3(MFN2): c.707C> T (p.Thr236Met) single nucleotide variant Pathogenic/Likely pathogenic rs773159585 GRCh37 Chromosome 1, 12058934: 12058934
40 MFN2 NM_014874.3(MFN2): c.707C> T (p.Thr236Met) single nucleotide variant Pathogenic/Likely pathogenic rs773159585 GRCh38 Chromosome 1, 11998877: 11998877
41 MFN2 NM_014874.3(MFN2): c.1126A> G (p.Met376Val) single nucleotide variant Likely pathogenic rs863224967 GRCh38 Chromosome 1, 12002069: 12002069
42 MFN2 NM_014874.3(MFN2): c.1126A> G (p.Met376Val) single nucleotide variant Likely pathogenic rs863224967 GRCh37 Chromosome 1, 12062126: 12062126
43 MFN2 NM_014874.3(MFN2): c.2256C> A (p.Tyr752Ter) single nucleotide variant Pathogenic rs863224968 GRCh37 Chromosome 1, 12071604: 12071604
44 MFN2 NM_014874.3(MFN2): c.2256C> A (p.Tyr752Ter) single nucleotide variant Pathogenic rs863224968 GRCh38 Chromosome 1, 12011547: 12011547
45 MFN2 NM_001127660.1(MFN2): c.730G> T (p.Val244Leu) single nucleotide variant Pathogenic rs879253777 GRCh37 Chromosome 1, 12059066: 12059066
46 MFN2 NM_001127660.1(MFN2): c.730G> T (p.Val244Leu) single nucleotide variant Pathogenic rs879253777 GRCh38 Chromosome 1, 11999009: 11999009
47 MFN2 NM_001127660.1(MFN2): c.479T> G (p.Val160Gly) single nucleotide variant Likely pathogenic rs879253861 GRCh37 Chromosome 1, 12057358: 12057358
48 MFN2 NM_001127660.1(MFN2): c.479T> G (p.Val160Gly) single nucleotide variant Likely pathogenic rs879253861 GRCh38 Chromosome 1, 11997301: 11997301
49 MFN2 NM_001127660.1(MFN2): c.526G> A (p.Gly176Ser) single nucleotide variant Likely pathogenic rs879253862 GRCh37 Chromosome 1, 12057405: 12057405
50 MFN2 NM_001127660.1(MFN2): c.526G> A (p.Gly176Ser) single nucleotide variant Likely pathogenic rs879253862 GRCh38 Chromosome 1, 11997348: 11997348

Expression for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type...

Search GEO for disease gene expression data for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a.

Pathways for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type...

GO Terms for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type...

Sources for Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type...

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....